Caxton Associates (New York)’s Aptiv APTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,071,454
Closed -$95.4M 478
2022
Q2
$95.4M Sell
1,071,454
-221,946
-17% -$22.6M 9.27% 3
2022
Q1
$155M Buy
+1,293,400
New +$172M 12.6% 2
2021
Q4
Sell
-600,468
Closed -$89.5M 553
2021
Q3
$89.5M Buy
600,468
+191,000
+47% +$29.7M 9.88% 2
2021
Q2
$64.4M Sell
409,468
-338,375
-45% -$49.6M 7.07% 4
2021
Q1
$103M Buy
747,843
+285,618
+62% +$41.5M 9.35% 1
2020
Q4
$60.2M Buy
462,225
+6,225
+1% +$692K 4.16% 4
2020
Q3
$41.8M Buy
456,000
+259,125
+132% +$21.7M 4.4% 2
2020
Q2
$15.3M Sell
196,875
-9,748
-5% -$671K 1.34% 11
2020
Q1
$10.2M Sell
206,623
-152,040
-42% -$11.9M 1.87% 9
2019
Q4
$34.1M Buy
+358,663
New +$32.8M 4.67% 4
2019
Q1
Sell
-9,531
Closed -$587K 375
2018
Q4
$587K Buy
+9,531
New +$691K 0.09% 98
2018
Q3
Sell
-4,818
Closed -$441K 402
2018
Q2
$441K Buy
+4,818
New +$449K 0.02% 257
2014
Q1
Sell
-15,000
Closed -$902K 173
2013
Q4
$902K Buy
+15,000
New +$868K 0.03% 175

Other funds holding APTV

Caxton Associates (New York)'s APTV Position: Q3 2022 in Review

Caxton Associates (New York) sold out of Aptiv (APTV) in Q3 2022, closing a stake of 1,071,454 shares — an estimated $95.4M sold.

Caxton Associates (New York) first reported a position in APTV in Q4 2013 and held it in 13 quarters. The position peaked at $155M in Q1 2022. 680 funds tracked by Wall St. Rank hold APTV as of Q3 2022.

  • Caxton Associates (New York) reported no remaining Aptiv position as of Q3 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 1,071,454 Aptiv shares in Q3 2022, an estimated $95.4M.
  • Caxton Associates (New York) first reported a position in Aptiv in Q4 2013 and held it in 13 quarters.
  • Caxton Associates (New York)'s Aptiv position peaked at $155M in Q1 2022.
  • 680 funds tracked by Wall St. Rank held Aptiv as of Q3 2022.

Based on Caxton Associates (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.